TriAgenics is raising $4 million to scale up manufacturing and obtain FDA 510(k) approval of our Zero3TBA product.

Facebook Twitter LinkedIn

TriAgenics has completed development of Zero3 TBA, a one-minute preventive care dental treatment for children ages 6-12 that stops wisdom teeth from ever forming. Kids can immediately go out and play following Zero3 TBA treatment because there is no recovery time and no possibility of painful dry sockets or infection.

Please refer to TriAgenics' Executive Summary using the following link:

Ready to Ask For Funding for your company?

Post a Funding Request

TriAgenics is no longer seeking funding.